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Insomnia surpasses other illness in prevalence (40–50%
population), influence on life, economic and time losses.
Pharmacotherapy is the most widespread method of in-
somnia therapy and prophylaxis. There are 28 hypnotic
drugs approved for use throughout Russia. These drugs
are equally effective and distinguished by frequency and
severity of adverse events, effects on quality of life, and
costs. The number of corresponding trials was insufficient
to make the quantitative comparison of these parameters.
We have classified the hypnotic drugs by their ascending
side effects and their descending quality of life into the fol-
lowing sequence: imovan (cyclopyrrolon) and ivadal (imida-
zopyridine), benzodiazepine (22), Donormyl (ethanola-
mine), barbiturates (3). Benzodiazepines are commonly
used drugs which accounted for their low costs, high effec-
tiveness, and prescribing habits. The next generation drugs,
imovan and ivadal, do not have the same sales and required
active promotion, both of which were complicated by the fi-
nancial crash during 1998. As we proposed, benzodiaz-
epines from CIS and Eastern Europe will be the most used
hypnotic drugs during the next 2 years in Russia.
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THE IMPACT OF ALCOHOL CONSUMPTION 
AND SMOKING ON SHORT-TERM HEALTHCARE 
COSTS IN A MANAGED CARE POPULATION
Field J, McCombs J, Sengupta N
University of Southern California School of Pharmacy, 
Department of Pharmaceutical Economics and Policy, Los 
Angeles, CA, USA
OBJECTIVE: To quantify the extent to which, from a
managed care perspective, future short-term healthcare
costs are impacted by current alcohol consumption and
smoking.
METHODS: Data for a random sample of 12,185 adult
patients from the Kaiser Permanente Patient Consulta-
tion Study (1992–1995) were used in this analysis. Using
multivariate predictive models, the logarithm of total
healthcare costs over 2 years was regressed on patient-
specific demographic and health status variables as mea-
sured in the baseline year, including measures of comor-
bidity. Alcohol consumption and smoking behaviors
were measured by self-report at baseline. Considering the
skewness of cost distribution, nonparametric tests were
also performed on the models.
RESULTS: Alcohol consumption proved statistically sig-
nificant in reducing total healthcare costs in the basic
model (14.97%, p  0.0001, R2  0.1413). However,
smoking was not found to statistically affect healthcare
costs in the basic regression model. These results were ro-
bust with respect to respecifications of the model that in-
cluded prior costs, levels of smoking and drinking, and the
presence of chronic disease states. Other covariates found
to significantly increase costs were age, female, single or
separated marital status, and being disabled. Compared to
White patients, Asian, Black, and Latino patients incurred
significantly lower healthcare costs in all models.
CONCLUSION: Results from this analysis showed a
negative relationship between alcohol consumption and
short-term healthcare costs while smoking was not found
to affect future costs. However, further studies are neces-
sary to focus on the history of health-related behaviors
rather than current patterns to more closely establish a
link between smoking and drinking and healthcare costs.
ECONOMIC AND OUTCOMES ISSUES OF 
RESPIRATORY DISEASE
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BARRIERS TO EFFECTIVE ASTHMA DISEASE 
MANAGEMENT: LIMITATIONS IN PHYSICIAN 
KNOWLEDGE OF TREATMENT GUIDELINES
Ricci J1, Stewart W1, Murphy S2
1Innovative Medical Research, Inc., Baltimore, MD, USA; 
2Glaxo Wellcome Inc., Research Triangle Park, NC, USA
OBJECTIVE: Effective asthma management requires in-
formed active involvement of patients and physicians.
One aspect, physician clinical knowledge, was evaluated
in this study as part of a comprehensive disease manage-
ment strategy to improve the quality of asthma care in a
managed care setting. 
METHODS: A pulmonologist administered a standard-
ized telephone interview to 68 primary care physicians
(72% participation rate). Participants were selected from
a random sample of HMO physicians with at least one
medical or pharmacy claim for asthma in the 6 months
prior to interview. The interview tested basic clinical
knowledge and specific applications of knowledge as out-
lined in the 1997 NIH/NHLBI Guidelines for the Diag-
nosis and Management of Asthma and covered: initial
asthma assessment and diagnosis; pharmacologic ther-
apy; control of factors contributing to asthma severity;
and patient management and education. Each domain
contributed 25 points to the overall score of 100 points. 
RESULTS: The mean overall score among the 68 partici-
pating physicians was 46  9. Overall, domain specific
scores were low. Knowledge regarding environmental
and non-environmental asthma triggers and commonly
recommended control measures was poor. More than
half under-assessed asthma severity based on symptoms
and pulmonary function. Almost 75% incorrectly stated
the indications for the use of long-acting inhaled beta2-
agonists. Almost half did not develop written action
plans with patients for asthma self-management. 
CONCLUSIONS: This survey revealed several key limi-
tations in physicians’ asthma knowledge. These limita-
tions will be addressed in a targeted and tailored physi-
cian educational intervention.
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OBJECTIVE: Periodic assessment of health status is criti-
cal for risk stratification and case management. This
study tested a simple telephone-based interview to assess
current asthma status (past hour) and determined the ex-
tent to which a questionnaire-based measure could pre-
dict peak expiratory flow (PEF).
METHODS: Thirty-nine adult asthma patients (56%
participation) were randomly selected from among man-
aged care patients with a medical or pharmacy claim for
asthma in the six months prior to interview. Volunteers
completed four weekly telephone interviews to assess
current asthma status. Using a portable device, two PEF
measurements were taken after each interview. The inter-
view screened for seven asthma symptoms. Using 10-
point anchored scales, volunteers also rated their abilities
to: 1) take a full and complete deep breath; 2) perform
self-defined moderately demanding activities; and 3) per-
form self-defined demanding activities, during the recall
period. Linear regression was used to model percent-pre-
dicted PEF. Covariates that contributed significantly to
improving model fit were retained. Linear and nonlinear
terms were tested. We fit the model using baseline data
and tested it on follow-up data. 
RESULTS: A linear model including the average of: 1)
the three scaled covariates (ability to take a full and com-
plete deep breath, perform moderately-demanding activi-
ties, and perform demanding activities); 2) body mass in-
dex; and 3) an interaction term, correlated well with
percent-predicted PEF (r  0.72). When applying the
model to follow-up data, the correlation coefficient re-
mained high (r  0.63). 
CONCLUSIONS: This 2-minute telephone-based inter-
view provides a rapid, simple, and accurate alternative to
more complicated and time intensive measures to assess
asthma status.
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DEVELOPMENT OF AN ASTHMA QUALITY OF 
LIFE QUESTIONNAIRE FOR NATIVE AMERICAN 
ADULTS (AQLQ-NAA)
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No asthma HRQoL scale specifically for Native Ameri-
can adults currently exists. 
OBJECTIVE: To develop and validate an Asthma Qual-
ity of Life Questionnaire for Native American Adults
(AQLQ-NAA). 
METHODS: A focus group was conducted to modify the
20 item Asthma Quality of Life Questionnaire-Marks
(AQLQ-M) to render it more culturally relevant for Na-
tive Americans. The AQLQ-NAA was constructed using
transcribed focus group proceedings. Adult asthmatics at
the Albuquerque PHS Indian Hospital and affiliated field
clinics completed the AQLQ-NAA. Higher scores on the
AQLQ-NAA indicate a more severe impact on HRQoL.
Principal components analysis (PCA) was conducted to
identify domains of the AQLQ-NAA. Cronbach’s alphas
for the AQLQ-NAA and its domains were calculated.
Construct validity of the AQLQ-NAA and its domains
was determined by correlating scores with pertinent
asthma related variables for the past 6 and 12 months. 
RESULTS: The AQLQ-NAA items have emphasis on re-
strictions in social, community and cultural activities.
Forty-one respondents completed the AQLQ-NAA. PCA
identified three components with eigenvalues above 1.00.
The components were named Community and Social Re-
strictions, Symptoms and Activity Limitations and Psy-
chological Impact. Cronbach’s alphas for the total
AQLQ-NAA and its domains were 0.94, 0.92, 0.88, and
0.87, respectively. Total AQLQ-NAA and most individ-
ual domain scores correlated significantly, and in the cor-
rect direction, with urgent care visits (p  0.05), physi-
cian visits (p  0.05), and total number of asthma
medications (p  0.05). All other correlations were in ex-
pected directions. 
CONCLUSIONS: The AQLQ-NAA and its domains
showed good internal consistency and construct validity
and should provide a valuable HRQoL outcome measure
of asthma-specific medical care interventions among Na-
tive Americans.
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COST BENEFIT ANALYSIS OF ASTHMA 
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Liu G, Kamath T, Huang A, Grewal A, Trinh H, Hong S, Kim J, 
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OBJECTIVE: The purpose of this study was to evaluate
the beneficial effects of the asthma education programs
for adults and children.
METHODS: Literature on previously published articles
on economic evaluations of asthma educational interven-
tions, impact on frequency and cost of healthcare utiliza-
tion was reviewed. Patients included in the study had
asthma that was either previously diagnosed or con-
firmed at the start of the study. After obtaining baseline
data, the patients were given asthma self-management
education programs for a duration of anywhere from 3
to 7 weeks after which they were followed up for a pe-
riod of 12 months. Both costs and benefits in this study
were defined in monetary terms. This study was done
from the payer’s perspective. The benefit of the education
program was measured by looking at the reduction in
health utilization rate and thereby calculating the cost
savings due to the intervention.
RESULTS: The clinical results revealed that the asthma
education program led to a significant decrease in the utili-
